Skip to content

Clinical trials

Phase 1 Scleroderma, Systemic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Phase 1 Country / region: China Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20232
20247
202519
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting22
Not yet recruiting9
Suspended3
Unknown status2
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanjing Bioheng Biotech Co., Ltd.4
The Children's Hospital of Zhejiang University School of Medicine4
Beijing GoBroad Hospital3
China Immunotech (Beijing) Biotechnology Co., Ltd.3
RenJi Hospital3
Chongqing Precision Biotech Co., Ltd2
PersonGen BioTherapeutics (Suzhou) Co., Ltd.2
Antengene Biologics Limited1
Beijing Boren Hospital1
Changhai Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic39
Lupus Erythematosus, Systemic26
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis20
Myositis19
Sjogren's Syndrome12
Autoimmune Diseases11
Antiphospholipid Syndrome5
Arthritis, Rheumatoid5
Immunoglobulin G4-Related Disease4
Anemia, Hemolytic, Autoimmune3

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.